Previous 10 | Next 10 |
2023-12-08 16:43:19 ET Gainers: IGM Biosciences, Inc. ( IGMS ) +9% . EF Hutton Acquisition Corporation I ( EFHT ) +6% . Biomea Fusion ( BMEA ) +5% . Larimar Therapeutics ( LRMR ) +2% . First Solar ( FSLR ) +1% . Losers: L...
2023-12-06 16:37:38 ET Verint Systems ( VRNT ) +11% . ZyVersa Therapeutics ( ZVSA ) +6% . Couchbase ( BASE ) +4% . Grayscale Solana Trust ( OTCQB:GSOL ) +4% . Cabaletta ( CABA ) +3% . Vivid Seats ( SEAT ) ...
2023-12-06 14:48:10 ET Penny Stocks – How News Makes These Small Caps Soar or Plunge Penny stocks , securities with share prices under $5, offer investors a chance at exponential returns with little upfront investment. However, investing wisely in penny stocks require...
2023-12-06 14:45:26 ET More on Bristol-Myers Bristol-Myers Squibb Is A Great Buy, But These 5+% Yielding Bargains Are Better Bristol-Myers Squibb: The Patent Expiry Challenge Bristol Myers Squibb: A Bitter Pill But Still A Buy Bristol Myers gets priority revi...
2seventy bio, Inc. (NASDAQ: TSVT), (“2seventy” or “the Company”), a leading immuno-oncology cell therapy company, today issued the following statement reiterating its commitment to maximizing shareholder value: As we indicated last month, the Board has commenced a ...
2023-12-06 12:32:02 ET More on 2seventy bio 2seventy bio, Inc. (TSVT) Q3 2023 Earnings Call Transcript bluebird bio And 2seventy bio - Spinner And Spun: The Better Bet In Cell Therapy FDA probing serious risk of T-cell malignancies in CAR-T cell therapy patients (upd...
2023-11-28 10:52:22 ET The U.S. Food and Drug Administration (FDA) on Tuesday said it was looking into reports of T-cell malignancies in patients who have been treated with CAR-T cell immunotherapies directed towards the proteins BCMA and CD19. The regulator said it had determined that ...
2023-11-20 12:59:05 ET Gainers: Mira Pharmaceuticals ( MIRA ) +58% . YPF ADR ( YPF ) +39% . Altamira Therapeutics Ltd ( CYTO ) +39% . ProKidney Corp ( PROK ) +35% . Soluna Holdings ( SLNH ) +32% . Safety Shot ( SHOT ) +...
2023-11-20 08:24:45 ET Losers: Syntec Optics Holdings ( OPTX ) -15% . Safe and Green Development Corp ( SGD ) -14% . Plus Therapeutics ( PSTV ) -14% reports new interim reSPECT-GBM phase 2 trial data at the society for NeuroOncology annual meeting. ...
2023-11-20 07:34:54 ET More on Bristol-Myers Bristol Myers Squibb: Bright Future Ahead Bristol-Myers Squibb Company (BMY) Management Presents at Jefferies London Healthcare Conference (Transcript) Bristol-Myers Squibb Company (BMY) Management Presents at 2023 UBS Bio...
News, Short Squeeze, Breakout and More Instantly...
- Divestiture Supports Company Focus on Development and Commercialization of Abecma - 2seventy bio, Inc . (Nasdaq: TSVT), announced today the completion of an asset purchase agreement (“APA”) by Novo Nordisk. Under the terms of the APA, Novo Nordisk has acquired th...
2024-06-06 06:15:03 ET Goldman Sachs analyst issues SELL recommendation for TSVT on June 6, 2024 05:06AM ET. The previous analyst recommendation was Buy. TSVT was trading at $4.56 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2seventy bio, Inc . (Nasdaq: TSVT) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available on the Investors and Media pa...